Free Access
Med Sci (Paris)
Volume 32, Number 12, Décembre 2016
Page(s) 1068 - 1071
Section Nouvelles
Published online 03 January 2017
  1. Macrez R, Stys PK, Vivien D, et al. Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities. Lancet Neurol 2016 ; 15 : 1089–1102. [CrossRef] [PubMed] [Google Scholar]
  2. Gielen M. Fonctionnement des récepteurs-canaux du glutamate : des proteines responsables de la transmission synaptique excitatrice. Med Sci (Paris) 2010 ; 26 : 65–72. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Reijerkerk A, Kooij G, van der Pol SMA, et al. The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J Neurochem 2010 ; 113 : 447–453. [CrossRef] [PubMed] [Google Scholar]
  4. Nicole O, Docagne F, Ali C, et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 2001 ; 7 : 59–64. [CrossRef] [PubMed] [Google Scholar]
  5. Samson AL, Medcalf RL Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 2006 ; 50 : 673–678. [CrossRef] [PubMed] [Google Scholar]
  6. Macrez R, Ortega MC, Bardou I, et al. Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis. Brain 2016 ; 139 : 2406–2419. [CrossRef] [PubMed] [Google Scholar]
  7. Lesept F, Chevilley A, Jezequel J, et al. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors. Cell death Dis 2016 ; doi: 10.1038/cddis.2016.279 [Google Scholar]
  8. Weksler BB, Subileau EA, Perrière N, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005 ; 19 : 1872–1874. [Google Scholar]
  9. András IE, Deli MA, Veszelka S, et al. The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab 2007 ; 27 : 1431–1443. [CrossRef] [PubMed] [Google Scholar]
  10. Kamat PK, Kalani A, Tyagi SC, et al. Hydrogen sulfide epigenetically attenuates homocysteine-induced mitochondrial toxicity mediated through NMDA receptor in mouse brain endothelial (bEnd3) cells. J Cell Physiol 2015 ; 230 : 378–394. [CrossRef] [PubMed] [Google Scholar]
  11. Lin L, Jin Y, Mars WM, et al. Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways. Am J Pathol 2014 ; 184 : 2757–2767. [CrossRef] [PubMed] [Google Scholar]
  12. Uhl B, Zuchtriegel G, Puhr-Westerheide D, et al. Tissue plasminogen activator promotes postischemic neutrophil recruitment via its proteolytic and nonproteolytic properties. Arterioscler Thromb Vasc Biol 2014 ; 34 : 1495–1504. [CrossRef] [PubMed] [Google Scholar]
  13. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008 ; 7 : 1091–1098. [CrossRef] [PubMed] [Google Scholar]
  14. Gleichman AJ, Spruce LA, Dalmau J, et al. Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 2012 ; 32 : 11082–11094. [CrossRef] [PubMed] [Google Scholar]
  15. Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 2012 ; 135 : 1606–1621. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.